FDA Investigator Lauren L Vajo

Lauren L Vajo has inspections in 3 countries as of 27 Sep 2023. Lauren L Vajo has collaborated with a combinined 3311 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
73
Last Inspection Date:
27 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100000519
Country:
United States of America, Belgium, Switzerland
Co-Investigator(s):
Addam S Reynolds, Adetutu M Gidado, Alberto A Viciedo, Amy L Singer, Amy M Cramer, Anastasia I Offordile, Angela E Glenn, Ankur C Patel, Ann Marie Montemurro, Annemarie B Randow, Annemarie Bodnar, Arduino Frankovic, Atul J Agrawal, Babatunde D Babalola, Barbara J Maulfair, Barbara J Rincon, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Bichsa T Tran, Burnell M Henry, Byungja E Marciante, Carol A Perry, Cary Greene, Cassandra L Abellard, Charles J Chacko, Christina K Theodorou, Claire M Minden, Colin E Tack, Daniel J Grabicki, David A Oluwo, David H Smith, Dawn L Wydner, Denise M Visco, Investigator, Dessa A Antoine, Devon Jenkins, Dhaval H Patel, Doreen P Canetti, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Guang Gao, PhD, Edward O'shaughnessy, Edward Oshaughnessy, Emest F Bizjak, Eric J Cunningham, Eric L Dong, BS, Eric Rothschild, Esteban Beltran, Frank J Marciniak, Frederick Razzaghi, Gamal A Norton, Gobiga Vanniyasingam, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Hitesh R Patel, Jacqueline Mdiaz Albertini, James R Birkenstamm, Jane Chen, Janet A Rajan, Javonica F Penn, Jean M Kelahan, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Jessica L Pressley, Jessica M Monteiro, Jogy George, John A Gonzalez, Jonathan S Helfgott, Jonee J Mearns, Jose Acruz Gonzalez, Jose M Cayuela, Jot R Klena, Joy Rkozlowski Klena, Junho Pak, Justine Tomasso, Karen E D'orazio, Karishma G Gopaul, Kelli F Dobilas, Kelli F Regeny, Kelli F Regenye, Kelly Doremus, Kenneth M Gordon, King, Kinh Q Mac, Ko U Min, Kristen E Rescigno, Kristy A Zielny, Kristy E Zuroski, Krystyna M Kitson, Kwong P Lee, Kyle D Covill, Lata C Mathew, PhD, Laurie B Frazier, Lawrence R Johnson, Lenahan Lenahan, Peter R, Li Li, Liatte Kreuger, PharmD, Lisa M Bellows, Loretta Nemchik, Luis A Dasta, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret M Annes, Margaret M Sands, Maria Estrella, Mark W Rivero, Martha T Olone, Melissa A Freeman, Melissa T Roy, Meredith L Sheridan, Meyer J Slobotsky, Michael Gurbarg, Michael R Klapal, Michael Rosner, Michael Serrano, Michelle D Haamid, Michelle L Johnson, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nancy Sheraga, Nerizza B Guerin, Nicholas A Violand, Omotunde O Osunsanmi, Pal S Mayasandra, Parul M Patel, Patrick C Klotzbuecher, Patsy J Domingo, Paul L Bellamy, Paul Mouris, Paula A Trost, Peter M Trunk, Peter R Lenahan, Prabhu P Raju, Preston M Lee, Pushpa S Jayasekara, Puspa Suresh Jayasekara, Ramanda C Gregory, Raymond L Cheung, Rebecca Rodriguez, Regina T Brown, Remache, Richard D Manney, Robert G Ruff, Rose Ljean Mary, Rose M Ashley, Russell J Glapioin, Russell J Glapion, Saleem A Akhtar, Samir C Gala, Sandra A Boyd, Sandra A Hughes, Sarah Forney, Satheesh K Podaralla, Schultz, Sean G Casey, Sena G Dissmeyer, Sharon K Thoma, PharmD, Sherri J Liu, Shirley S Wen, Simone E Pitts, Srinivas R Chennamaneni, PhD, State Agency, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Steven M Weinman, Susan M Halsted, Susan M Jackson, Tamala P Bogan, Tamala P Magee, Tania E Vizcaino, Tara G Bizjak, Tara R Gooen, Tracey L Harris, Tressa T Lewis, Unnee Ranjan, Valerie C Reed, Victoria Spivak, Wayne J Meyer, William J Muszynski, William R Chang, Xiaohan Cai, PhD, Yiyue Zhang (nmi), PhD, Yvesna C Blaise, Yvins Dezan

Lauren L Vajo's Documents

Publish Date Document Type Title
February, 2014 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2014-02-26
May, 2012 FDA 483 Biochem Laboratory, Inc - Form 483, 2012-05-14
April, 2010 FDA 483 Sun Pharmaceutical Industries, Inc. - Form 483, 2010-04-28
June, 2013 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2013-06-07
January, 2011 FDA 483 Cispharma Inc. - Form 483, 2011-01-24
March, 2013 FDA 483 Siegfried USA, LLC - Form 483, 2013-03-26
April, 2011 FDA 483 Maquet Cardiovascular, LLC - Form 483, 2011-04-01
October, 2011 FDA 483 Vantage Specialty Ingredients, Inc - Form 483, 2011-10-11
October, 2011 EIR Vantage Specialty Ingredients, Inc - EIR, 2011-10-11
September, 2011 FDA 483 Perma Pure LLC - Form 483, 2011-09-19
April, 2014 EIR Convatec Inc. - EIR, 2014-04-16
July, 2013 EIR Everest Life Sciences LLC - EIR, 2013-07-15
August, 2010 EIR Reliance Private Label Supplements - EIR, 2010-08-03
May, 2014 FDA 483 Flawless Beauty LLC - Form 483, 2014-05-16
May, 2012 EIR Biochem Laboratory, Inc - EIR, 2012-05-14
November, 2010 FDA 483 H & P Industries, Inc. - Form 483, 2010-11-10
June, 2014 FDA 483 Lingraphicare America, Inc. - Form 483, 2014-06-24
August, 2011 FDA 483 Access Bio, Inc. - Form 483, 2011-09-12
October, 2012 FDA 483 Pacon Manufacturing Corporation - Form 483, 2012-10-24
June, 2011 FDA 483 Biochem Laboratory, Inc - Form 483, 2011-06-15
November, 2011 FDA 483 Roche Molecular Systems, Inc. - Form 483, 2011-11-01
April, 2011 FDA 483 Response Maquet Cardiovascular, LLC - Form 483R, 2011-08-30
February, 2014 EIR Hikma Pharmaceuticals USA, Inc. - EIR, 2014-02-26
August, 2012 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2012-08-28
August, 2013 FDA 483 Novel Laboratories, Inc. - Form 483, 2013-09-11
July, 2010 FDA 483 Ohm Laboratories Inc. - Form 483, 2010-07-14
December, 2011 FDA 483 Physitemp Instruments, LLC - Form 483, 2011-12-27
April, 2014 FDA 483 Convatec Inc. - Form 483, 2014-04-16
April, 2011 FDA 483 A.P. Deauville, LLC - Form 483, 2011-04-21
October, 2012 EIR Pacon Manufacturing Corporation - EIR, 2012-10-24
November, 2011 EIR Isomedix Operations Inc. - EIR, 2011-11-04

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more